shafi_banner

Bayanan Gastroenteroscopy na Bid-Win na Kwata na 1 da Kwata na 2 na 2025 a Kasuwar Sin

A halin yanzu ina jiran bayanai kan tayin farko na gwajin endoscopes daban-daban na rabin shekarar. Ba tare da wata damuwa ba, a cewar sanarwar ranar 29 ga Yuli daga Medical Procurement (Beijing Yibai Zhihui Data Consulting Co., Ltd., wanda daga nan ake kira Medical Procurement), an rarraba matsayi ta yanki da alama, tare da ƙarin bayani ta hanyar cikakkun saiti, endoscopes guda ɗaya, da ƙwarewa.

 

Da farko, ga alkaluman tallace-tallacen cikakkun kayan aiki da madubai masu tabarau ɗaya a rabin farko na 2025 (hoto na gaba/tushen bayanai: Sayen Lafiya)

 1

Jimillar adadin cikakkun kayan aikin shine biliyan 1.73 (83.17%), kuma na madubai guda ɗaya shine miliyan 350 (16.83%). Idan muka mayar da shi zuwa cikakken adadin (cikakkun kayan aikin + madubai), sannan muka haɗa shi da matsayin kasuwar endoscope na gastrointestinal na 2024 (tushen bayanai: Bidi Bidding Network), rabon da canje-canje a rabin farko na shekara sune kamar haka:

 2

Dangane da darajar, idan aka kwatanta da 2024, waɗannan alkaluma gaskiya ne:

Manyan samfuran da aka shigo da su daga ƙasashen waje guda uku sun kai kashi 78.27% na tallace-tallace, wanda ya nuna karuwar kashi 5.21% daga kashi 73.06% a shekarar 2024. Kason tallace-tallace na Fujifilm ya karu da kashi 4%, tallace-tallace na Apollo ya ragu kaɗan, kuma tallace-tallace na Pentax ya karu da kashi 1.43%. Wannan yana nuna cewa bayan an samar da samfurin da aka shigo da shi (Fujifilm) don gwaje-gwajen gastroenteroscopes na musamman, gasa tsakanin samfuran cikin gida zai ragu a shekarar 2025, har ma yana fuskantar gasa mai girma a cikin gida.

 

Saita ƙima: Farashin endoscope mai amfani sau ɗaya/Saita farashi (an ƙididdige shi bisa ga bayanan siyan magani)

 3

Haɓakar Fujifilm ta samo asali ne daga ingantaccen ingancin endoscope na ciki (ci gaba da tallata LCI da BLI) da kuma samar da cikakkun saiti na VP7000. Katin shaida da farashin jigilar kaya suna jan hankalin abokan ciniki na tsakiya zuwa na sama. Fujifilm yana yaƙi da Olympus sosai kuma yana bin Olympus sosai, yana mai da hankali kan cutar kansa ta farko. Kasafin kuɗin Olympus ba zai iya wuce takardar shaidar shigo da kaya ba, don haka Fujifilm yana da yuwuwar cin nasarar yarjejeniyar. Wannan yana nuna a cikin rabon tabarau ɗaya/cikakken saiti na Fujifilm na (0.15). Duk da cewa Fujifilm yana da adadin cikakkun saiti, rabon tabarau/saitinsa ya yi ƙasa da Olympus da Fujifilm sosai. Wannan yana nuna cewa Fujifilm a halin yanzu yana mai da hankali kan katunan shaida na gida da cikakkun saiti, wanda hakan yana da fa'ida.

 

Kwanciyar hankali a Olympus: Olympus, ɗan wasa na 1, ta himmatu ga matsayinta. Bayan shekaru uku na juriya, duk da raguwar kaso a kasuwa, ta gano muhimman fannoni na ƙwarewa kuma tana matsawa zuwa ga kasuwa mai tsada. Ta sabunta iyakokinta bisa ga yawan tarin manyan layukan, ta daidaita da manufofi da kuma daidaitawa da dabarun samar da kayayyaki na cikin gida. Wataƙila, Olympus ma ta fusata da wahalhalun da take fuskanta wajen haɓaka cikakkun kayan aiki saboda rashin izinin shigo da kaya. Tsarin GIS (Sashen Maganin Gastrointestinal) a duniya a shekarar 2026, tare da mai da hankali sosai kan ilimin gastroenterology, na iya taimakawa wajen hanzarta gabatar da sabbin layukan a cikin China. Manyan layukan tallace-tallace sun kasance CV-290, sai CV-1500. Bayan wurin Olympus, ana sa ran kasuwarta za ta ƙaru da >5%. Bayanai kan adadin cikakkun layukan da layukan guda ɗaya a rabin farko na 2025 (Hoton da ke ƙasa/ tushen bayanai: Sayen Lafiya)

 4

A cewar bayanan da aka samu daga likitoci: An sayar da na'urorin endoscopes na ciki guda 952 da na'urorin endoscope guda 1,214 a duk fadin kasar cikin awa 1. Canzawa mai tsauri:

 5

Kasuwar Pentax ta 1H ta kasance kashi 4.34%, ƙaramin ƙaruwa daga kashi 2.91% a shekarar 2024. Pentax tana da magoya bayanta masu aminci, kuma idan aka yi la'akari da rabon gilashin ido/saita na 2025 na 1H (0.377), Pentax ta zarce Olympus (0.31). Kasuwar babban gilashin ta ta fi ta masana'antun cikin gida girma. A cikin wannan ƙoƙarin ƙarshe, Pentax tana ƙara scopes zuwa manyan gilashin ta (duba bayanan gastroenteroscope na Q1 da Bidi Bidding Network ta fitar: jerin gastroenteroscopes na 10). Ƙara ɗan kasuwa abu ne da za a iya fahimta. Bugu da ƙari, idan aka kwatanta da Olympus da Fujifilm, ƙarancin farashin saitin ya sa ya zama abin sha'awa. Labari mai daɗi ga Pentax shine an bayar da lasisin shigo da sabon gastroscope na i20, wanda ke haɗawa da babban gilashin 8020c. Labari mara daɗi shine har yanzu ba a amince da babban gilashin 8020 ba.

 6

Sonoscape da Aohua, musamman ma dangane da yawan dala, za su ga raguwar kason su na Sonoscape nan da shekarar 2024. Wannan na iya faruwa ne saboda yawancin ayyukan tallafin kiwon lafiya na ƙasa ana aiwatar da su a rabin na biyu na shekara, wanda hakan ke haifar da ƙaruwar kason kasuwa a kwata na huɗu.

 

Abu ɗaya da bai kamata a yi watsi da shi ba shine matsakaicin farashin Sonoscape a kowace saiti ya fi na Aohua ƙasa da yuan 280,000. Muna fatan Sonoscape ta ci gaba da mai da hankali kan endoscopy kuma ba ta da saurin kamuwa da tasirin ciki da waje. Rabon sikelin/saitin Sonoscape (0.041) da na Aohua (0.048) suna da alaƙa da ƙaramin tushe na kayan aikin endoscopy, ƙarancin farashin sake siye tsakanin abokan ciniki masu ƙarancin inganci, da kuma mai da hankali kan ayyukan abu ɗaya. Bayan kammala saiti, ci gaba da kulawa zai samar da ƙarin sakamako. Sonoscape da Aohua suna buƙatar ƙarfafa dabarun sake siyan su, suna magance ƙalubalen biyu kai tsaye. Tabbas, nazarina na iya zama son kai, domin farashin Aohua a kowace saiti ya fi yuan 280,000 girma fiye da na Sonoscape, wanda ke ba su damar biyan kuɗin ƙarin sikelin. Wataƙila Aohua ta haɗa da ƙarin sikelin a cikin saitunan da suka ba da shawarar.

 

A matsayi na 678910, sayar da raka'a biyu ko uku akan yuan miliyan biyu abin takaici ne.

Concemed, babbar kamfanin kera kayayyaki a matakin farko na gida, tana da matsakaicin farashi mai yawa a kowace na'ura, inda aka bayar da RMB miliyan 15 a cikin watanni shida da suka gabata. Asibitoci masu nasara sun haɗa da asibitoci na birni da na manyan kamfanoni, tare da farashin daga RMB miliyan 700,000 zuwa RMB miliyan 2.5. Manyan samfuran na'urorin sune 1000s da 1000p, yayin da na'urorin ke da 1000 da 800 RMB. Baya ga Aohua Kaili, Concemed shine kamfani na farko da ya bayar da cikakkun na'urori na sama da na ƙasa, yana ba da mafi kyawun ƙima. Da zarar ka shiga da wuri, da wuri za ka amfana. Concemed shine kamfanin da aka fi jin daɗinsa a cikin gida bayan Aohua Kaili. Za mu ga yadda na'urorin ƙara girman Concemed ke aiki daga baya.

 

Kamar yadda aka saba, tsarin samfurin yayi kama da Mindray, amma salon ya bambanta. Na gwada shi kuma yana da kyau kamar Concemed. Bari mu ga yadda yake aiki a ƙarshen shekara.

 

InnerMed ya fara da na'urar duban dan tayi ta endoscopic kuma ya ƙare da yin endoscopy bayan ɗan lokaci. Maganin ƙaramin bincike + endoscope na gaba ya dace da ƙarin ƙungiyoyi masu matsakaicin matsayi kuma yana da yuwuwar amfani.

 

Huger, wanda samfuransa suka ƙunshi sassa daban-daban, ana iya ɗaukarsa a matsayin babban ɗan'uwan endoscopy. Da farko ya mayar da hankali kan sashen numfashi, kuma yanzu a fannin tsarin narkewar abinci, yana fatan samun babban ci gaba.

 

Lynmou, ban san da yawa game da wannan ba. Shin R&D da samarwa sun bambanta? Ta yaya muke sadarwa? Tunda an samar da shi a cikin gida, shin kun yi la'akari da ƙirƙirar ƙaramin injin aiki? Shin ya fi dacewa da 'yan Asiya da mata?

 

A ƙarshe, sayar da cikakken kayan aiki kamar cin nasara a birni ne; mamaye wani yanki kamar cin nasara a wani yanki ne; sayar da ruwan tabarau ɗaya kamar noma gona ne; noma mai ci gaba yana haifar da girbi mai ci gaba. Dukansu suna da mahimmanci. Mabuɗin sarrafa nau'ikan ruwan tabarau na musamman shine samar da sabis na dogon lokaci.

 

Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China wanda ya ƙware a fannin amfani da endoscopic, kamar suƙarfin biops,hemoclip,tarkon polyp,allurar sclerotherapy,feshi catheter,gogewar cytology,waya mai jagora, kwandon cire dutse, cathete na magudanar ruwa ta hanci da sauransu waɗanda ake amfani da su sosai a cikin EMR, ESD, ERCP.

 

Kayayyakinmu an ba su takardar shaidar CE, tare da amincewar FDA 510k kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma suna ba wa abokin ciniki yabo sosai!

7


Lokacin Saƙo: Satumba-19-2025